Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial

OBJECTIVES: The aim of this study was to investigate the effects of citrulline (Cit) supplementation on inflammatory markers and liver histopathology in patients with non-alcoholic fatty liver disease (NAFLD). In this clinical trial, fifty NAFLD patients were assigned to receive 2 g/day Cit or place...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Res Notes
Autori principali: Darabi, Zahra, Darand, Mina, Yari, Zahra, Hedayati, Mehdi, Faghihi, Amirhosein, Agah, Shahram, Hekmatdoost, Azita
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Research Note
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6376741/
https://ncbi.nlm.nih.gov/pubmed/30767788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-019-4130-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi